| Literature DB >> 19349972 |
Cheuk Hei Ho1,2, Leslie Magtanong1,2, Sarah L Barker1,2, David Gresham3, Shinichi Nishimura4,5, Paramasivam Natarajan6, Judice L Y Koh1,2, Justin Porter7, Christopher A Gray7, Raymond J Andersen7, Guri Giaever1,2,8, Corey Nislow1,2, Brenda Andrews1,2, David Botstein3, Todd R Graham6, Minoru Yoshida4, Charles Boone1,2,4.
Abstract
We present a yeast chemical-genomics approach designed to identify genes that when mutated confer drug resistance, thereby providing insight about the modes of action of compounds. We developed a molecular barcoded yeast open reading frame (MoBY-ORF) library in which each gene, controlled by its native promoter and terminator, is cloned into a centromere-based vector along with two unique oligonucleotide barcodes. The MoBY-ORF resource has numerous genetic and chemical-genetic applications, but here we focus on cloning wild-type versions of mutant drug-resistance genes using a complementation strategy and on simultaneously assaying the fitness of all transformants with barcode microarrays. The complementation cloning was validated by mutation detection using whole-genome yeast tiling microarrays, which identified unique polymorphisms associated with a drug-resistant mutant. We used the MoBY-ORF library to identify the genetic basis of several drug-resistant mutants and in this analysis discovered a new class of sterol-binding compounds.Entities:
Mesh:
Year: 2009 PMID: 19349972 PMCID: PMC3856559 DOI: 10.1038/nbt.1534
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908